Friday, April 20, 2012

EASL:New Clinical Practice Guideline on Alcoholic Liver Disease Published

New Clinical Practice Guideline on Alcoholic Liver Disease Published

BARCELONA, Spain -- April 19, 2012 -- The European Association for the Study of the Liver (EASL) today announced the publication of a new clinical practice guideline in the area of alcoholic liver disease.

Alcoholic liver disease is the leading cause of liver disease in eastern and western Europe, yet there has been limited research investment in this area and the development of clinical practice guidelines is therefore both timely and necessary.

The EASL Clinical Practice Guidelines on Alcoholic Liver Disease, build on the issues raised at the Monothematic Conference on Alcoholic Liver Disease (Athens 2010) and have been developed with 3 main aims: to (1) provide physicians with clinical recommendations; (2) to emphasise the fact that alcohol can cause several liver diseases, all of which may coexist in the same patient; and (3) to identify areas of interest for future research, including clinical trials

The guidelines cover the burden of alcoholic liver disease, management of alcohol abuse and dependence, pathogenesis, risk factors for disease progression, diagnosis, alcoholic hepatitis, alcoholic cirrhosis, and liver transplantation.

The guidelines will be published in August 2012 issue of the Journal of Hepatology.

In addition, EASL has also published a revised clinical practice guideline on the management of chronic hepatitis B virus (HBV). This update incorporates changes to a number of areas including: new indications for liver biopsy and the treatment of HBeAg-negative patients; the recommendation for less frequent HBV DNA testing under entecavir or tenofovir; and the provision of more detailed recommendations for specific sub-groups, particularly HBV and pregnancy and HBV and immunosuppression.

The complete practice guideline can be found here:

SOURCE: European Association for the Study of the Liver

No comments:

Post a Comment